Shao, X.; Liu, L.; Weng, C.; Guo, K.; Lu, Z.; Huang, L.; Di, Z.; Guo, Y.; Di, G.; Qiao, R.;
et al. Leveraging an mRNA Platform for the Development of Vaccines Against Egg Allergy. Vaccines 2025, 13, 448.
https://doi.org/10.3390/vaccines13050448
AMA Style
Shao X, Liu L, Weng C, Guo K, Lu Z, Huang L, Di Z, Guo Y, Di G, Qiao R,
et al. Leveraging an mRNA Platform for the Development of Vaccines Against Egg Allergy. Vaccines. 2025; 13(5):448.
https://doi.org/10.3390/vaccines13050448
Chicago/Turabian Style
Shao, Xianyu, Lijing Liu, Changzhen Weng, Kun Guo, Zhutao Lu, Lulu Huang, Zhenhua Di, Yixuan Guo, Guorong Di, Renmei Qiao,
and et al. 2025. "Leveraging an mRNA Platform for the Development of Vaccines Against Egg Allergy" Vaccines 13, no. 5: 448.
https://doi.org/10.3390/vaccines13050448
APA Style
Shao, X., Liu, L., Weng, C., Guo, K., Lu, Z., Huang, L., Di, Z., Guo, Y., Di, G., Qiao, R., Wang, J., Yang, Y., Sun, S., Zhuang, S., & Lin, A.
(2025). Leveraging an mRNA Platform for the Development of Vaccines Against Egg Allergy. Vaccines, 13(5), 448.
https://doi.org/10.3390/vaccines13050448